<SEC-DOCUMENT>0000950170-25-063540.txt : 20250505
<SEC-HEADER>0000950170-25-063540.hdr.sgml : 20250505
<ACCEPTANCE-DATETIME>20250505161007
ACCESSION NUMBER:		0000950170-25-063540
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250505
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250505
DATE AS OF CHANGE:		20250505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oric Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001796280
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				471787157
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39269
		FILM NUMBER:		25913017

	BUSINESS ADDRESS:	
		STREET 1:		240 E. GRAND AVE.
		STREET 2:		2ND FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 388-5600

	MAIL ADDRESS:	
		STREET 1:		240 E. GRAND AVE.
		STREET 2:		2ND FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>oric-20250505.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-02T18:15:30.1595+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:oric="http://www.oricpharma.com/20250505" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_80246073-f633-491c-865c-0e4a74405a2a" name="dei:EntityCentralIndexKey" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b">0001796280</ix:nonNumeric><ix:nonNumeric id="F_3745995c-b7e8-4bb7-918e-09803bc39944" name="dei:AmendmentFlag" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="oric-20250505.xsd"/></ix:references><ix:resources><xbrli:context id="C_986a34b5-c1d7-4941-b34d-26248f38897b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001796280</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-05</xbrli:startDate><xbrli:endDate>2025-05-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.44in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1efe76a2-53eb-4e33-9d0a-76166f413991" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of The Securities Exchange Act of 1934</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_028b7034-0608-449f-a8b4-781eced48a3d" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">May 5, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09118753-2756-45b9-88c0-67b4f51ea74c" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:33.527%;box-sizing:content-box;"/>
     <td style="width:1.68%;box-sizing:content-box;"/>
     <td style="width:31.546%;box-sizing:content-box;"/>
     <td style="width:1.68%;box-sizing:content-box;"/>
     <td style="width:31.566%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:middle;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:middle;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:middle;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_28ebae7a-d0b8-4582-b87d-e37402dac0f0" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b22e17ff-bcb2-420b-8dc4-8c60c42a1bf7" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39269</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_07f4a8ab-c5d4-44d5-b462-3d620683fdeb" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">47-1787157</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">of incorporation)</span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File Number)</span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:bottom;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2dfec7d9-80ba-4250-9bad-74d2c1a0b565" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">240 E. Grand Ave</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ab89bef8-d577-42a8-ba2a-4e4c566179b8" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nd</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Floor</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41f668cd-955f-4357-9b59-9ac6ee45a513" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">South San Francisco</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f428cd28-5b90-419e-a446-780904cc4004" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d7f82e1-059e-48f6-8fa5-7e20b4ad988a" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94080</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices, including zip code)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d57ea8d-f287-44b7-8167-ef79e484e22b" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(650)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_53dae7c1-8ca8-41d0-af54-cc9fe80996a2" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">388-5600</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not Applicable</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former name or former address, if changed since last report)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:0.556%;border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.46%;box-sizing:content-box;"/>
     <td style="width:96.54%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_67938873-6375-4a4d-8a08-0bb59e043d27" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:0.556%;border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.66%;box-sizing:content-box;"/>
     <td style="width:96.34%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_b588ddd5-39f7-4746-a261-7cae5315d985" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:0.556%;border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.46%;box-sizing:content-box;"/>
     <td style="width:96.54%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_dbdba790-45cf-4078-a875-62ca37e41aab" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:0.556%;border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.46%;box-sizing:content-box;"/>
     <td style="width:96.54%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_9f9f193c-3b7f-48c1-9a42-8521773eaec9" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.042in;vertical-align:top;padding-bottom:0in;padding-right:0.042in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:37.909%;box-sizing:content-box;"/>
     <td style="width:1.137%;box-sizing:content-box;"/>
     <td style="width:24.182%;box-sizing:content-box;"/>
     <td style="width:0.998%;box-sizing:content-box;"/>
     <td style="width:35.774%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_f793a11e-233a-455c-b520-ba8f70043cab" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7dabb238-628a-4b1a-b113-0a12c7b99e63" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ORIC</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">The </span><span><ix:nonNumeric id="F_6d1b598c-820e-4ae7-b745-e10f1049f6f2" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Global Select Market</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b80923f3-ed6d-4760-992c-8f0e8b43215c" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_be45a929-e29e-4b3d-8937-0f507b4c20e4" contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.44in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 5, 2025, ORIC Pharmaceuticals, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_section_8_other_events"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the information furnished in this Item 2.02 and Item 9.01 (including Exhibit 99.1) shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span><span id="fis_other_events"></span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="fis_unidentified_table_2"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:10.952%;box-sizing:content-box;"/>
     <td style="width:1.277%;box-sizing:content-box;"/>
     <td style="width:87.772%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:1pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;margin-right:0.13%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;margin-right:0.13%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="oric-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release dated May 5, 2025</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;margin-right:0.13%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;margin-right:0.13%;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;margin-right:0.13%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded with the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.44in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="eolpage3"><span id="fis_signatures"></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="text-indent:4.253%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.18%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:4.08%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:3.1%;box-sizing:content-box;"/>
     <td style="width:1.16%;box-sizing:content-box;"/>
     <td style="width:44.16%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ORIC PHARMACEUTICALS, INC.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;Date: May 5, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Dominic Piscitelli</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dominic Piscitelli</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.148%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>oric-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:49.5pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img48504584_0.jpg" alt="img48504584_0.jpg" style="width:128px;height:36px;"></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:9.38pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Announced focused registrational clinical development plans for lead programs, extended cash runway, and accelerated/augmented corporate milestones</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Presented preclinical data supporting potential best-in-class profile of ORIC-944 in combination with AR inhibitors to treat prostate cancer at the 2025 AACR Annual Meeting</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Announced clinical trial collaboration and supply agreement with Johnson &amp; Johnson to evaluate ORIC-114 in combination with subcutaneous amivantamab for the first-line treatment of NSCLC patients with EGFR exon 20 insertion mutations</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expects to report five data readouts across ORIC-944 and ORIC-114 clinical programs over the next 15 months, with potential initiation of registrational trials for both programs in 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and investments of approximately $224 million expected to fund operating plan into 2027</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOUTH SAN FRANCISCO and SAN DIEGO, CA &#x2013; May 5, 2025 &#x2013; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results and operational updates for the quarter ended March 31, 2025.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;In the first quarter, we made significant progress across our pipeline, announced focused registrational development plans for our two lead programs, extended our cash runway, and accelerated key corporate milestones,&#x201d; stated Jacob M. Chacko, M.D., president and chief executive officer. &#x201c;Looking ahead, we expect to share multiple clinical data updates across both programs over the next fifteen months. We remain on track to initiate the first Phase 3 trial of ORIC-944 in mCRPC in the first half of 2026, with registrational development of ORIC-114 in first-line NSCLC expected to begin later that year.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First Quarter 2025 and Other Recent Highlights</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC-944</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: a potent and selective allosteric inhibitor of PRC2</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with apalutamide in patients with metastatic castration resistant prostate cancer (mCRPC). </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Presented preclinical ORIC-944 data demonstrating synergistic activity and improved progression-free survival (PFS) when combined with androgen receptor pathway inhibitors (ARPIs) in models of prostate cancer at the 2025 AACR Annual Meeting.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Announced updated program milestones and development plans to initiate first Phase 3 registrational trial for ORIC-944 in mCRPC in 1H 2026.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC-114</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: a brain penetrant, orally bioavailable, irreversible EGFR/HER2 inhibitor</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Announced a clinical trial collaboration and supply agreement with Johnson &amp; Johnson and initiated a trial to evaluate ORIC-114 in combination with subcutaneous (SC) amivantamab for the 1L treatment of patients with non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Announced updated program milestones and registrational development plans to focus ORIC-114 in 1L NSCLC and plans to initiate first Phase 3 trial in 2026. </font></div></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Highlights:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Extended projected cash runway into 2027 (from previous guidance of late 2026), and accelerated/augmented corporate milestones, based upon favorable enrollment and focused registrational clinical development plans for two lead programs.  </font></div></div><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Anticipated Program Milestones:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC anticipates the following upcoming milestones:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC-944 (mCRPC): </font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2212;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1H 2025: Combination dose escalation data with AR inhibitors(s)</font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2212;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2H 2025: Updated combination dose escalation data with AR inhibitors(s)</font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2212;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4Q 2025 / 1Q 2026: Combination dose optimization data with AR inhibitor(s)</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC-114 (NSCLC): </font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2212;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2H 2025: 1L EGFR exon 20, 2L EGFR exon 20, 2L+ HER2 exon 20 and 2L+ EGFR atypical data  </font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2212;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mid-2026: 1L EGFR exon 20 combination with SC amivantamab </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 1L EGFR atypical data </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First Quarter 2025 Financial Results</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents and Investments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Cash, cash equivalents and investments totaled $223.8 million as of March 31, 2025, which is expected to fund the current operating plan into 2027.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R&amp;D Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Research and development (R&amp;D) expenses were $24.6 million for the three months ended March 31, 2025, compared to $22.0 million for the three months ended March 31, 2024, an increase of $2.7 million. The increase was due to a net increase in external expenses related to the advancement of product candidates, as well as higher personnel costs, including additional non-cash stock-based compensation.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">G&amp;A Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: General and administrative (G&amp;A) expenses were $8.1 million for the three months ended March 31, 2025, compared to $7.0 million for the three months ended March 31, 2024, an increase of $1.0 million. The increase was primarily due to higher personnel costs, including additional non-cash stock-based compensation.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About ORIC Pharmaceuticals, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients&#x2019; lives by </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overcoming Resistance In Cancer. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC&#x2019;s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">www.oricpharma.com</font></font><font style="color:#1d2228;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and follow us on </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">X</font></font><font style="color:#0000ff;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or</font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LinkedIn</font></font><font style="color:#1d2228;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cautionary Note Regarding Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, statements regarding the continued clinical development of ORIC-944 and ORIC-114; the potential of ORIC-944 and ORIC-114; clinical outcomes, which may materially change as patient enrollment continues or more patient data become available; advantages of ORIC-944 in preclinical models, including synergies with ARPIs and improved PFS; the development plans and timelines for ORIC-944, ORIC-114 and ORIC&#x2019;s other programs; plans underlying ORIC&#x2019;s clinical trials and development; anticipated program milestones, including timing of program and data updates and the initiation of registrational trials; the period over which ORIC estimates its existing cash, cash equivalents and investments will be sufficient to fund its current operating plan; and statements by the company&#x2019;s chief executive officer. Words such as &#x201c;believes,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;plans,&#x201d; &#x201c;expects,&#x201d; &#x201c;intends,&#x201d; &#x201c;will,&#x201d; &#x201c;goal,&#x201d; &#x201c;potential&#x201d; and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained herein are based upon ORIC&#x2019;s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those projected in any forward-looking statements due to numerous risks and uncertainties, including but not limited to: risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics and operating as an early clinical stage company; ORIC&#x2019;s ability to develop, initiate or complete preclinical studies and clinical trials for, obtain approvals for and commercialize any of its product candidates; changes in ORIC&#x2019;s plans to develop and commercialize its product candidates; the potential for clinical trials of ORIC&#x2019;s product candidates to differ from preclinical, initial, interim, preliminary or expected results; negative impacts of health emergencies, economic instability or international conflicts on ORIC&#x2019;s operations, including clinical trials; the risk of the occurrence of any event, change or other circumstance that could give rise to the termination of ORIC&#x2019;s license and collaboration agreements or its clinical trial collaboration and supply agreements; the potential market for ORIC&#x2019;s product candidates, and the progress and success of competing therapeutics currently available or in development; ORIC&#x2019;s ability to raise any additional funding it will need to continue to pursue its business and product development plans; regulatory developments in the United States and foreign countries; ORIC&#x2019;s reliance on third parties, including contract</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacturers and contract research organizations; ORIC&#x2019;s ability to obtain and maintain intellectual property protection for its product candidates; the loss of key scientific or management personnel; competition in the industry in which ORIC operates; general economic and market conditions; and other risks. Information regarding the foregoing and additional risks may be found in the section titled &#x201c;Risk Factors&#x201d; in ORIC&#x2019;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on May 5, 2025, and ORIC&#x2019;s future reports to be filed with the SEC. These forward-looking statements are made as of the date of this press release, and ORIC assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contact:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dominic Piscitelli, Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">dominic.piscitelli@oricpharma.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">info@oricpharma.com</font></font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC PHARMACEUTICALS, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDENSED BALANCE SHEETS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:60.14%;box-sizing:content-box;"></td>
     <td style="width:1.06%;box-sizing:content-box;"></td>
     <td style="width:15.82%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.06%;box-sizing:content-box;"></td>
     <td style="width:18.92%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(unaudited)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="7" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and short-term investments</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">203,723</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,960</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,710</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,290</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:25pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">211,433</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">262,250</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term investments</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,039</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,021</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,924</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,365</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,968</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:25pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">242,858</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274,142</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="7" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders' Equity</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,160</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,548</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued liabilities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,457</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,298</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:25pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,617</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,846</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:35pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,503</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,174</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:25pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,120</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,020</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:35pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:6.48%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:5pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders' equity</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">219,738</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">243,122</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:25pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' equity</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">242,858</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274,142</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORIC PHARMACEUTICALS, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_operations_comprehensive_lo_2"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATEMENTS OF OPERATIONS </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AND COMPREHENSIVE LOSS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.86%;box-sizing:content-box;"></td>
     <td style="width:1.06%;box-sizing:content-box;"></td>
     <td style="width:12.24%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:4.54%;box-sizing:content-box;"></td>
     <td style="width:1.06%;box-sizing:content-box;"></td>
     <td style="width:12.24%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br>March 31,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,640</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,960</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,078</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,030</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:20pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,718</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,990</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(32,718</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(28,990</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,697</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,979</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(30,021</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(25,011</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive loss:</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Unrealized loss on investments</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(170</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(420</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive loss</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(30,191</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(25,431</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.42</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.37</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,040,580</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67,349,551</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
     <td style="width:33.333%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:15.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img48504584_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img48504584_0.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (T!] # 2(  A$! Q$!_\0
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MV53_  [*ZNP_;^\1Q[?[4^'&B7F!%O\ L&O7VF[B ?.V_:+#5=@D.#$#O\D
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M;3PLHDCB:%51/#%AI"1P%&)>VC5;:24+/)$TZ+(OD6K?MN?MFZ\AAUK]K?\
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M_P#;A_Z/*_:L_P#$A_B[_P#-A7RG11_9V7_] &"_\):'_P K\E]P?ZT\3_\
M11Y]_P"'?,/_ )H\E]Q]6?\ #=_[</\ T>5^U9_XD/\ %W_YL*/^&[_VX?\
MH\K]JS_Q(?XN_P#S85\IT4?V=E__ $ 8+_PEH?\ ROR7W!_K3Q/_ -%'GW_A
MWS#_ .:/)?<?5G_#=_[</_1Y7[5G_B0_Q=_^;"C_ (;O_;A_Z/*_:L_\2'^+
MO_S85\IT4?V=E_\ T 8+_P ):'_ROR7W!_K3Q/\ ]%'GW_AWS#_YH\E]Q]6?
M\-W_ +</_1Y7[5G_ (D/\7?_ )L*/^&[_P!N'_H\K]JS_P 2'^+O_P V%?*=
M%']G9?\ ] &"_P#"6A_\K\E]P?ZT\3_]%'GW_AWS#_YH\E]Q]6?\-W_MP_\
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M?QUUCLDS:AI6PM92A3E4HR:D\/B'2I^T4:E.I3I8BCB*%(HHHKPS]""BBB@
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M_C-X^_\ )Y/$'_L?U?\ U'PX5\E_MJ_\D-O_ /L9/#W_ *435]:5\E_MJ_\
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M_P &W_\ R?#\5/\ LU/QQ_ZMWX&5_:Y7\Z^)7_)45O\ L#P?_IMG^HGT4/\
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M?#UZ51*4*M&M2E.G5ISBU*$X2E&2::;04445!N%%%% !7\V'_!5>+5OVR/\
M@HC^Q=_P3LM-1OH?AU"D?Q:^+4.EW3PM=0WG_"0:AJ\=V5<+::KX>^&7@C7/
M^$;O7V^1=_$)L1W4DD$-?TGU_.]8_P#$K_X.+M:_MP.O_"1_LX1?\(=YUUA7
M\CX9Z3]J-I$R2[D']@^*@UK&UMB1+F]+MM>.?ZKA*7L<9F6.@D\1EN19ICL(
M]^3$PI1H0JI=72C7G56FG)S*S2:_'?&FFL?D?"G#M>4EEG%?B+P?P_G48W7M
M\IK8VKC\1A92CK"&,J9?0PDG=*2K\DE*,W&7]".DZ3IF@Z5IFAZ+86FE:-HN
MGV6DZ3I=A!':V.FZ9IUM'9V%A96T2K%;VEG:PQ6]O!$JQQ0QI&BA5 '\&7AK
M]F_P/^US_P %I_C5^SU\2-5\5Z)X+^(/[5G[9']LZGX(OM(TWQ1;?\(I=_&;
MQOIW]F7NO:%XETF'SM6\-6-O>_:]$O?,T^6[B@^S7,D-W!_>[7\ 4G[3-C^Q
MW_P6*^/'[1NI>$;OQW9?#K]JS]K[S_"ECK$.@W6J_P#"7:O\7O L?E:M<:?J
MD-I]AF\3QZD^^PG\^.S>V7RFF6:/W_#U8N:XG6!<WCYY)66$<914WBY>T^KN
M,ZC4%/VS@U*;44]9-*[/S/Z3LLDH5?"&7$$:*X<H\?8.6=PJTJM3#K)*<L&\
MRC4H8>$ZTZ*P,:RG2H4Y590O"E"4W%/]R_''_!MK^RU>^&M1@^&OQQ^/WAOQ
M@T3G2=5\<7GP[\:^&H9Q%+Y:ZCH&@> ? &J7,33F$N]MXEM7CB64+'([J4_E
M^^'/Q!^,7[ W[6DVJ^&M7DTWXE? 3XJZ[X)\66.BZA=#1O%0\&>+)] \9^#=
M1:)8'U7PMXF?2+O3;J":%&EMY8;R!+:_M[6:#]P?C!_P<H?$W6-,N]/^!O[.
MWA/P-?7-F(H?$?Q"\5W_ ([N-/NI#(LUQ::%HVF>$+&62%#')9O?7UU;B<$W
M=A=0*89/(_\ @C7^PQ\5?VG_ -INP_;5^.GAV[U+X4>%O%NO_$@>)?%]MY'_
M  M[XQ7M_J-]97^BV36B1:SI_ASQ=/+XJUW5H5M](CUW3+'1HC>R/J=E9_8Y
M77S_ "?*<XQ?&U6G6P+PZCA\'B:V&JXBO5E&I&6'C*CSQ:Q"<::A*<W&5ZBC
M",:DI?AG&&7>&W''&O V3> &"Q.!X@IYI[;-,\RK YM@\MRW!4:N%G1S2I2Q
MWL:L999-5<5/$TJ%",X<N'E5KUJN'IP^]/\ @XG_ &;=&\6_!;X7?M=>&;'9
MXG^'VO:9X \7:C! UM-J/P[\:?:[WPU>ZBTD:7"OX:\8B"RTV)UAE3_A-]0$
MX)AA2/\ 7K_@FY\=]3_:2_8@_9X^+&OZ@=5\5:GX(7PWXPU"63?>ZAXL\ :K
MJ/@/7]5U%=S-'?Z[?^')=>G!$:RC5$N8(H[6>!:\)_X+9W^C67_!,[]H^/65
M$HU!?A98:7 )?)EFUE_C-\/KFP:!L@L;(VTFI3Q CSK*RNHF#([*W%?\$'M*
MU+3_ /@F[\*[N^FEEM==\9_%G5=&20$);:;#\0=<T26& EW!B;6-&U6X8JL8
M\^>8;"P:23\^Q$WC. ,'5KZU,LXBJX'!SEK+ZK7P7UFI14FKM>U:=E9*-**7
MPI+^FLLP\<D^DMGF%R^T<-Q9X883B'.\/2]RG_:V79['*,-C9TT^52EA:;A=
M\U253&5:DM:DIS_8NBBBOAC^APHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *XCX@?$CP+\*_#EUXL^(/B;2_"^A6@(:\U*8K)<S!2ZVFG64*RWVJ7\BJ
MQAT_3;:ZO)@&,<#!6(^)OVF_^"@WP_\ @X=0\)?#H6'Q&^)$!FM;@07!E\'^
M%[M 48:WJ5G*KZK?V\V%ET+1YU>-X[BVU+5-(NHEAF_"?XH?%SXB?&7Q'+XI
M^(_BC4/$FJ-YB6J7#K#IVE6TA4FRT;2K=8M/TJT^1"\-E;Q>?(OGW+3W+/,_
M\.^/WTWN!?"N6-X;X*CA./>.:/M*%:GA\2WPQD.)C>,HYOF6&ES8_%T*FE3*
M<JJ>TC*G5P^.S#+*\(QE_4WA%]%WBKCZ.&SOB>6(X2X5J\E6E.M1MGN;496D
MI9=@J\>7"8:K#6&8X^/)*,J=;"X/'4I.4?T0_:'_ ."F?BWQ4U]X9^!-G<>"
M?#[>9;2^--3B@D\7ZE'ED:72K3=/9>&[>5<^5,QOM8VF.>*?2+@- GY::CJ6
MHZQ?76J:M?WNJ:G?3/<WNHZC=3WM]>7$AS)/=7=S)+<7$TAY>6:1W8\LQ-4J
M*_Q\\3/%_P 0_%[.'G/'G$>,SBI3G4E@,N4OJV2Y13J/6CE64T.7!X./(HPJ
M5HTY8O$J$)XS$XFJG4?^C? _ASP=X=9:LMX3R7#9="<8+%XUKV^9YC."_B8_
M,*O-B,0^;FG&DYQP]!RE'#4*--J"****_-#[<**** "BBB@ HHHH **** "B
MBB@ HHHH **** /W^_X)4_\ )O7C+_LLWB'_ -0CX=U^F5?F;_P2I_Y-Z\9?
M]EF\0_\ J$?#NOTRK_HO^BK_ ,H[^$W_ &2F'_\ 4K%'^,WC[_R>3Q!_[']7
M_P!1\.%?)?[:O_)#;_\ [&3P]_Z435]:5\E_MJ_\D-O_ /L9/#W_ *434?2N
M_P"4:O'+_LV7%O\ ZJ<0>!X4_P#)RN!O^RFRG_U+IGXYT445_P I!_JP%%%%
M !1110 4444 %%%% !1110 4444 %%%% %FSO;S3KJ"^T^[N;&]M95FM;RSG
MEMKJVF0Y26"X@=)894/*R1NK*>017W+\(?VV/$GA\VVB_%&WF\5:.H2&/Q%9
MI#'XELD!"JU[$6AM-;BC4 ,[FTU(_/--=W\N(V^$:*_6/"7QP\4/ _/5GWAO
MQ7F&0U:DZ<LQRSG^MY#G5.GHJ&<Y)B.?+\?'D<J=.O4HK&813G/ XK"UFJJ^
M4XLX(X7XWP+P'$F4X?'PC&2P^)M[+'X*4MZF"QM/EQ&'?,E*4(S=&JXQC7I5
M87B_Z%O!_C?PIX_T>+7O"&N6.N:9*0K2VDN9;6; 8VU_:2!+NPNU4AFM;R&"
M<(R2;#&Z,W55_/;X+\>>+?AYK,6O^#];O-%U&/:LK6SYMKV!7#_9-1LY ]K?
MVC, S6]W%+%N D55D5'7]1O@E^V!X5\?&T\/^.Q9^#O%LGEPPW32M'X9UNX<
MA56SN;B1WTF[E8X6QU&=X9&*):ZC<3S+:I_N7]&G]H=X=>,$\OX3\1H8'PU\
M0L1[/#8>6(Q3CP;Q'BY6A&&49KBYN>48W$5+JCD^=57SSE1PV!S;,\555&/\
M.>)7T>>(N$(XC-N''7XEX?I\U2HJ=)/.<NHK5RQ>%HQ4<91IQUGC,%!<L5.K
M7PF%I0<W]F4445_HJ?SJ%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %?R]_P#!S'_R(O[(_P#V-GQ?_P#3/X K^H2O
MY>_^#F/_ )$7]D?_ +&SXO\ _IG\ 5]?P%_R5N4?X\7_ .H&+/Q#Z1__ "9;
MC?\ Z\9+_P"M)DQ_)'1117],G^2P4444 %%%% !1110 4444 %%%% !1110
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ME6U#_P!-FEU_HO5_G0_\%5/^4A_[6?\ V5;4/_39I=?J/A5_R.<Q_P"Q8_\
MU*PY_'_TRO\ DA>%O^RLC_ZI\S/S]HHHK]W/\YPHHHH **** /Z!/^#;_P#Y
M/A^*G_9J?CC_ -6[\#*_M<K^*/\ X-O_ /D^'XJ?]FI^./\ U;OP,K^UROYU
M\2O^2HK?]@>#_P#3;/\ 43Z*'_)HL'_V/L[_ /3U(****^!/Z4"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MADA\2'7M#+RW>M:+80_TX>,OCU\#?AWI;ZYX^^,GPL\%:/&DKMJ?BKX@>%-
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M 'A_PUJ%];+L@U3Q!!9K<>)]9C39$576O$ESJNK89%<&\._+[B?Q-_X)&?\
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M]_4445_N ?Q"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%'_ !%O_JG_ /S*_P#X-#_B2G_JY?\ YIO_ .-9_E/T5_JP44?\1;_ZI_\
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M#\5/^S4_''_JW?@97]KE?Q1_\&W_ /R?#\5/^S4_''_JW?@97]KE?SKXE?\
M)45O^P/!_P#IMG^HGT4/^318/_L?9W_Z>I!1117P)_2@4444 %%%% !1110
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M;14</!+333IH86G^%O#&DW(O-*\.:#IEV$>,76GZ1I]E<B-P Z">VMXY0C@
M.H;:P R#6[117(VY.\FV^[;;^]GM0IPIKEIPA3C>_+"*BKZ*]HI*]DE?R17N
M[2TO[>:SOK:WO+2X0QSVMW#'<6\\9()2:"97BD0D E75E) XXKB]2^%?PPUJ
M*.#6/AQX"U:"*3SHH=2\'^'K^*.7:R>;''=:=*B2;&9-ZJ&VLRYP2#WE%.,Y
MP^"<H=?=DXZ]]&B*N'P]=6KT*-9-<K56E"HG&]^7WXO2^MMKZGS9X@_8S_9!
M\6>:?$W[*_[.FO23/=2O/JOP4^&][=">^S]KN8KN?PV]U#=W#?/)=PS1W)D"
MR^:)%5AX!XK_ ."3/_!.?QFLR:O^RC\.;,3XWGPI-XH\!LNV*.$>2_@?Q#X=
M>W^2-2?L[1;I3).V9I99'_1*BNVEFN:4&G0S+'T6MG2QF(IM>G)45CP<9P;P
MAF*E',.%.&\>I?$L9D65XI2TM[RKX6:>FFO30_$7QM_P;]?\$]_%0N/[ TOX
MO_#5IBS0_P#"&_$N;44M,MN5(E^(>C^.VDC7[A%Q)-(R9_>B3$@^*?B)_P &
MT/A6=)I_A-^U1X@TJ1$)M]*^(GPYTW7TN'R^%FU_PUXB\--:)@Q@R)X:O3E7
M/EX=1'_4A17LX;C3BC"V]GG.*FETQ/LL7?R;Q5.LW?O>_9IGPN:^ GA!G"DL
M3P+D^'<K^]E7UO)7%O9QCE.)P4%9ZI.#AT<6M#^&_P"*'_!O?^WGX),TW@9_
MA%\9+3:SVT'A+QU_PC.M.%5?W=U9?$C3?!VCVT[OO$:V_B*^@,81Y;F)V:)/
MS,^+W[%G[6GP&6[G^+G[._Q:\%Z99&1;CQ%?>#=7O?"*F(9D\OQEI%OJ'A6X
M"+\[-;ZQ*H0A\[""?],.BOIL%XI9U1:6-P>!QL%:[@JF%K2[^_"56BM.V'T>
MNJT/R;/OH>\ XY3GD.=\0Y!7E?DA6GA<XP%/M;#UJ6$QLK/?FS-W6BY7J_\
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M+HZ:<RPO,TDI284445^K'P 4444 %%%% !1110 4444 %%%% !1110 4444
M<=XI^'O@;QO$8?%OA/0?$'R[$FU+3;6>\A!&W-M?&,7MJVWY0]M<1.!P& KY
M4\:_L,_#?6A+<>#=7UGP7>-N,=K(Y\0Z*O4A1;W\T.K)D_+YAUF547D0,1@_
M;E%?C_B-X >"_BS3K1\0?#?A;B+%5HN,LWJY=# <0P4DDU1XCRN6!SZ@G:+:
MHYC"+<8MIN*M]APYQ_QIPG*#X?XDS3+J4&FL)'$.OE[:=_?RW%*O@*CZ7GAY
M.S:32;O^+OCS]D;XQ^"A/=6FC0^,M*B#-]M\*2O?72Q@,P\W19H[?6#)M4EQ
M9VE["C87[0Q9-WS/<6UQ9SS6MW!-:W-O(T4]O<1/!/!*A*O%-#*JR1R(P*LC
MJK*000#7]'5>=>._A-\._B5;F'QEX5TS5IA&8X=3\HVFLVHVX46VKV;0:A$B
MG:WD?:&MI&1/.@D50M?YR^+7[*?AO'PQ69>"_'6,R#&/GJ4>&..(RS7)IS=^
M6AAN(<NP\,VRVA!)*+QN6\05YMOGQ$59K^B^$OI59EAW2PW&F14<?15HSS/(
MVL+C8Q6]2KE^(J/"8FH]W['$Y?!+X:;V/P$HK]#/B3^PGJEI]HU'X6^(%U6!
M0TB^&_$KPVFI<#/E6.MPQQ:==N[';%%J%KI4<4:YEU"9SD_"OB;PEXG\&:D^
MD>*]!U3P_J*;B+75+.:U:6-6*>?;/(HBN[9F!\NZM9)K>4?-'*ZD$_Y6^+OT
M=O&+P-QKP_B-P3F>48&=9T<'Q%AHQS3AC,&W:G]4S[ .OEZK58N-2.!Q57#9
ME3A*/UC!49W@OZHX1\1.#N.*/M.',ZPN+KQ@IULNJMX7,\.K>][; 8A4\1R1
M=XNO2A4PTI)^SK36ISM%%%?B9]J%%%% !1110 445^CG[,/[*LC26'Q&^*.F
M;(D\B]\+^$;Z-2TS%4FM]8U^V;.R),J]CI%PHD>0>?J,21)';7'[+X&>!7'G
MT@.-\'P7P/@)3?-2KY]GV)IU5DO#&4RFXU<TS?$PBU"-HU(X+!P;Q>98F*PV
M$ISGSRI_&\<\=9#P!DE;.L\Q"CI.G@,!3E#Z[F>+44XX7"4I-.3NXNM6:]EA
MJ;]K6DHV4HOV6_V6_M/]G?$OXEZ=_HW[J^\*>%+Z+_CYZ26VN:Y;2#_CV^[+
MINF2K_I/R7EXGV;R8;G]*:**_P"FGP'\!^!OH]\#83@K@K"<TY>SQ7$/$.*I
MTUG'$^<*GR5<RS*K"_+"-Y4\OR^G)X7+<*U0H*4Y5Z]?_,[CSCS//$'/:V=9
MU6M%<U++LNI2D\'E>#<KQPV&B[7D[*6(Q$DJN)JKGG:*ITZ9115/4-0L-)L+
MW5=5O;73=,TVUN+[4-0OKB*TLK&RM(GGNKN[NIW2&WMK>%'EGGE=(XHT9W95
M4D?L]2I"E"=6K.%.G3A*I4J5)*$*<()RG.<Y-1C",4Y2E)I12;;21\9"$ZDX
MPA&4YSE&$(0BY3G.32C&,4FY2DVE&*3;;22N7**^3/@K^V9\'/CIX[\4^ /"
MNH75EJ^C74W_  C;ZPB647CS2+2%6O=6\.I(RS!K:9+F5M*O$AU-](6#5U@"
M?VG;:3]9U\YPGQGPKQWE/]N\'9_EG$>3K&8S+WF&58F&)P\<9@*TJ&*P\I1U
MC.G-*<.9*-;#U*&+H.IA<10K5/:X@X:S_A3,/[*XDRC'9+F/U;#8M8/'T)4*
MSPV+I*K0K*,M)1G%N,K-NE6A5P]50KT:M.!1117TQX84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!6O;*SU*TN=/U&TM;^PO8);:\LKVWBNK2[MID,<UO<VTZ20SP2HS)+
M%*CQR(2K*02*_,?]HO\ X(\?L&?M&+>W^H_!^S^%/BZ[C=5\9?!*2W^'E]',
MX!:YN?#5E9W/@#5;J60+)<7NK>$+W4)F\P_;4::5G_4&BNS!9ACLNJJM@,9B
M,)4TO+#UITN:W2:BU&<>\9J46M&FCP\^X9X=XHPCP/$6297G6%::C2S+!4,6
MJ;>\Z$ZL)5,/46\:M"5.I%I.,TTF?Q6_M3_\&]?[2?PLBU/Q-^SIXKT7]H7P
MI:B:Y'AB>*#P3\4K6V1?-,=OI5_>W'A?Q,;:-9$:33?$.G:OJ,JQ+IWAAY9Q
M;Q?@SXT\$>,_AQXFU7P9\0/"?B/P1XNT*X-IK/ACQ9HNH^']>TNY !\F_P!)
MU6WM;ZU=E(=/-@421LLB%D96/^IQ7S/^TM^Q]^SI^USX5;PK\>?AEH'C$0VT
MMMHOB;[.NG>./"IE+2>;X7\86*PZ[HX$["XFL8;MM)U"5$75=.OX 86_2<E\
M3\=AW"CG="..HW2>+P\84<7%?S3I+EP]>W:*P\M6W.3T?\I\??1#X=S*%?'<
M 9E5X?QUI3AD^9U*V/R6M+5JE1Q<O:YG@+MW=2I+,X:*$:-.+<E_F;T5^]_[
M>/\ P0D^-_[/$6L_$;]G"XUC]H#X16GVJ_O= @L(3\7_  5IL;!A]OT/342#
MQ]96\; SZQX1L+;4U59[F\\(:?IUK-J!_!%E9&9'4JRDJRL"K*RG!5@<$$$$
M$$ @C!K]ARO-\NSG#+%9;BJ>)I:*:BW&I1FU?DK4I)5*4[:I3BN9>]%RBU)_
MPSQ?P3Q1P)FDLGXIRC$Y7B_>E0E42J83&T8M+ZQ@,92<\-C*%VDYT*DW3D_9
MUHTZL94XI1117I'RH4444 %%%% !7M/[/7Q^^)7[,'Q?\%_&WX3:S_8WC/P5
MJ:7EL)UDFTK6M-F4P:QX:\0V44L#:AX?\0:<\^F:M:+-!.;:<SV-U9:C!:7M
MOXM16=6E3KTJE&M3A5HUH2IU:<XJ4*E.<7&<)Q=U*,HMIIJS3L=.#QF+R[%X
M7'X'$5L)C<%B*.*PF*P]25*OAL3AZD:M"O1J0:E3JTJD8SA.+3C**:V/],#]
MCS]JSX=_MF_ 7P=\<_AU*+>VUR!M/\4^%YKN&ZU7P-XUTU(D\0^$=7:-8F,^
MGW$L=SIUY);6@UK0;W2->@MH;75($'U!7\ 7_!(K]OJ\_8H_:)LM,\8:K*GP
M!^,-WI?A;XI6<\I-CX8O&G-OX;^)MNC.JP2^%+FZDB\0/'O-WX0O=9'V6]U*
MQT3[+_?S#-%<113P2QSP3QI-#-"ZR1312*'CEBD0LDD<B,'1T8JZD,I((-?S
M-Q?PY/AS-)4::E+ 8KFK8"I)MOV=UST)R>]3#RDH2;=YTY4ZCLYN,?\ 6GP/
M\4Z'BCPA2QN(E3I\1Y0Z6 XCPL%&">*=-NAF5&G&RAA<SIPG6IQ24:.(IXO"
MQYHX>,YR4445\H?LP4444 %%%% !1110 4444 %%%% !1110 4444 %?YT/_
M  54_P"4A_[6?_95M0_]-FEU_HO5_G0_\%5/^4A_[6?_ &5;4/\ TV:77ZCX
M5?\ (YS'_L6/_P!2L.?Q_P#3*_Y(7A;_ +*R/_JGS,_/VBBBOW<_SG"BBB@
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MAB\TK_[-E& O9MXO'U%[*,U%\ZPU'VV,J03='#5;6/YO?@[\#/C!^T%XPM?
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M-@,%#W80Y98K&XJ:?U? 8&BY1]OC,3-<E*'-&$$IUJ]2EAZ5:M3\W_X+ ?\
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MT7_'MTDMM<URVD'_ !\_=ETW3)5_T;Y+R\3[3Y,-M^B]%%?]-7@;X&\#> '
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MAFR1O$>F1I':6_B&Q63R(_%&AVX=@T,A,,>M64(4:7J4R[(8M/O-/+?;U?\
M0)P'QUPSXD\*91QGPCF-/,LCSG#JOAZL;1KX>K'W,3@,=04I2PN88&LIX?&8
M6;<J-:$DI3@X3E_D+Q7PKGG!6?YCPUQ%@YX'-<LK.E6IN\J56#7-1Q6%JVBJ
M^$Q5)QK8:O%)5*4XMJ,N:,2BBBOKSYT**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5?\ (YS'_L6/_P!2L.?Q_P#3*_Y(7A;_ +*R/_JGS,_/VBBBOW<_SG"BBB@
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M+JD_X"30RV\LMO<1203P2/#-#,C12PRQ,4DBEC<*\<D;JR.CJ&1@58 @BO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW)M2"BBBOCC]T"BBB@ HHHH **** "BBB@ HHHH **** "O\Z'_@JI_RD/\
MVL_^RK:A_P"FS2Z_T7J_SH?^"JG_ "D/_:S_ .RK:A_Z;-+K]1\*O^1SF/\
MV+'_ .I6'/X_^F5_R0O"W_961_\ 5/F9^?M%%%?NY_G.%%%% !1110!_0)_P
M;?\ _)\/Q4_[-3\<?^K=^!E?VN5_%'_P;?\ _)\/Q4_[-3\<?^K=^!E?VN5_
M.OB5_P E16_[ \'_ .FV?ZB?10_Y-%@_^Q]G?_IZD%%%%? G]*!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117\^W_!<7_@H_)^SU\/9
MOV6O@[KWV;XU?%;09?\ A.==TRY9-0^&GPSU6*6VECMIX2&L/%OCB$SV.ES(
MZWVB^'QJ&M0BSO[[PYJ*^GD^4XK.\PP^78.-ZM:7O3:;A0I1UJ5ZK6U.G'5]
M92Y81O.<4_DN..,\GX!X9S+BC.ZO+A,!2_=4(2BL1C\;4O'"9?A(R^+$8JK:
M$7;DI4U4Q%9QH4:LX_E]_P %M_\ @IO)\?\ QCJ7[*7P1UX/\$/A_K(C^(?B
M32Y\P?%/Q[HUTVZQMKJ&1DO/ W@Z]A5;#9BVU[Q)#/K.+NPTSPY>'^>FBBOZ
MBR?*<)DF7T,OP<.6E1C><VE[2O6DE[2O5:WJ5&KOI&*C""4(1BO\@N..-,ZX
M_P")<PXGSVM[3%XVIRT</"4GALOP5-R6%R_!PE\&&PT'9:<U6K*KB:SG7K5:
MDRBBBO3/D0HHHH **** "BBOL3]BK]B'XT_MS_%6'X<?"C34M-)TO[%?_$'X
MAZO#,/"GP^\/7-R8?[1U6>/:;[5KP1W*>'_#-G(-3UZYMKCROLNFV.K:KIN&
M)Q.'P>'JXK%5J=##T(.I5K5)*,(175M]6VHQBKRE)J,4Y-)^CE.4YGGN98/)
M\GP6(S',\PKQP^#P6%INI7KU97:C&*T48Q4IU*DW&G2IQG5JSA3A*2X#]F/]
MESXS?M=?%/2/A'\$_"T_B'Q#?F.YU;4YR]KX;\'Z +B*"]\4>+M8\N2'2-#T
M_P U3(^R>^O[AH=,T:QU/5[NRT^Y_NU_X)[_ /!,WX*?L%>#XKC1[:U\<_'#
M7-+CM?'?Q@U2PC34;CS2DUUX?\&VLIG;PKX02=4S8VTS:AK;VUM>>(+V]DMK
M"WT[WK]C_P#8W^"O[$_PIL_A=\'="\CS_L=]XT\9:D$G\6?$#Q);VBVTNO\
MB._ _P"NW]F:-9"#1="@N)K?2K*#S[J6Y^K*_GSB[C?%9].>"P+J87*(RMR7
MY:V-Y7I4Q-G[M*ZO3PZ;BM)U7.:BJ?\ IIX)?1]RCPYH8?/N((8;-^-:M-2]
MORJM@<A4X^]A\K4XVJ8M)N&(S.48U&G*CA%1H2JRQ)1117P)_284444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!3U#4+#2;"]U75;VUTW3--M;B^U#4+ZXBM+*QLK2)Y[J[N[J=TAM[:W
MA1Y9YY72.*-&=V55)'\^?[;'[;%_\;K^[^''PXN[K3?A)IMUMO;U1+:7OQ!O
M;24-'?7T;!)K?PW;S(LVD:1,J274B1:MJT2W2V-CI/[Q_$7X?^&?BGX*\0^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%%% !1110 4444 %%%,DD2)'EE=(XHT:2221@B1H@+.[NQ"JBJ"S,Q 4 DD
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MA<N]G+]SF>8J]+'9Q+E;C5A*4987+I-RC'!0=>E[.6.KQ91117W9_.H4444
M%%%% !117MO[.W[/GQ-_:C^+_@_X)_"313K/C#QA?BWCDF$\>D:#I<.)-6\3
M>)+ZWM[IM,\.Z%9[[W4[[R)I!&J6UG;W>H7-G9W&=6K2H4JE>M4A2HTH2J5:
MM22C"G3@G*<YR=E&,8IMMNR2.G!8+%YCC,+E^ PU;&8W&XBCA<)A</3E5KXG
M$UZD:5&C1IP3E.I4J2C"$8IMR:1Z3^QA^QI\7/VWOC)I?PG^%FG>3:0_9]3\
M>>.+^&7_ (1OX?>%/M"PW6N:S/&/WUW-\]MH.AP-]OUW4MMM;B&TAU"_L?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJF)JXBC/GPC1\J4445_11_EV%%%% !1110 4444 :.CZ/JWB'5]*T#0=,O\
M6M=US4K'1]%T?2K2>_U/5M6U.ZBLM.TS3K&U26YO;^_O)X;6SM+>.2>XN)8X
M8D>1U4_WX_\ !*+_ ()S:-^PK\&EU;Q?:6&H_M%?$[3K"_\ B=KL?V>Z'A>R
M81WEA\,M OHC(ATO092DFOWEI/);^(O$L4M\LUQI>GZ EG^6/_! [_@G5&([
M;]N;XQZ 6E8WNG_L\>'M8L\)&@+V6L?%N2VFY>1S]KT'P.\\82-!K'B6"&1Y
M/"^JP?U65^'>(O%3Q5:>08"I_LV'FEF-6#TQ&(@TUADUO2P\E>JOMUURM)44
MY_Z%?1<\&XY1@:'B3Q)A5_:V9T&^&,)7AKEV5UX.,LVG&2]W&9G3DXX1I)T<
MNDZBE)X]QH%%%%?E!_9P4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y6_\
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MC<#A_:\1<(JOG>5.$>:MB,)"FGG.6PM>4OK6#I+$T:4(NI5QN!P=*%E4E?\
MH]HHHK_?,_R2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M55KI1>68C+:<GVY<3F-!I_S*/H_WTHHHK^;S_5,**** "BBB@ HHHH ****
M"BBB@ HHHH *_P Z'_@JI_RD/_:S_P"RK:A_Z;-+K_1>K_.A_P""JG_*0_\
M:S_[*MJ'_ILTNOU'PJ_Y'.8_]BQ_^I6'/X_^F5_R0O"W_961_P#5/F9^?M%%
M%?NY_G.%%%% !1110!_0)_P;?_\ )\/Q4_[-3\<?^K=^!E?VN5_%'_P;?_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,+Q/X<TKQAX;U_PGKMO]JT7Q-HVIZ#JUME09M.U>RFL+
MR-697".UO/($<JVQ]K@$J*_DA^(_@?5/AIX]\8> -9^;4O"'B'5=!N)A&T4=
MVNGW<D-OJ$"/\PM=1MEAO[0GE[:XB?\ BK^ONOP._P""I/PQ_P"$;^+WAGXE
MV5OLT_XC^'19ZE*D?#>)O" MM/FDFD4;5:X\/W7A^*!) 'D.GW;HTBQNL/\
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M_P#D^'XJ?]FI^./_ %;OP,K^UROYU\2O^2HK?]@>#_\ 3;/]1/HH?\FBP?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"U_PS-([7'@[X@:K##&QW)%I6NZ;I>K6VSG*;]4?6RT>-H($@=FE94_2RO\
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M3=N; X?&M-2C%/\ 3FBBBOYI/]80HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *_SH?\ @JI_RD/_ &L_^RK:A_Z;-+K_ $7J_P Z'_@JI_RD/_:S_P"R
MK:A_Z;-+K]1\*O\ D<YC_P!BQ_\ J5AS^/\ Z97_ "0O"W_961_]4^9GY^T4
M45^[G^<X4444 %%%% '] G_!M_\ \GP_%3_LU/QQ_P"K=^!E?VN5_%'_ ,&W
M_P#R?#\5/^S4_''_ *MWX&5_:Y7\Z^)7_)45O^P/!_\ IMG^HGT4/^318/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8J"=OK&)P=%^:C7C7M]]!/Y']&_16P4<5XPY37:N\MRC/<;%Z>[*I@)Y=?\
M\!Q\HZ:^]VN?O31117\Y'^I84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^/'_  5KT59-
M)^"7B-5 >TU'QQHL[@KF1=0MO#5]:JP)WD1'3+PH57:/.DWD%HP?Q6K^DO\
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MO^2HK?\ 8'@__3;/]1/HH?\ )HL'_P!C[.__ $]2"BBBO@3^E HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKXV_:_\
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M .$E;_Y$/^(R>%7_ $<'A/\ \/6#_P#EI^UU%?BC_P /_/\ @GA_T,GQ6_\
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MQ&3PJ_Z.#PG_ .'K!_\ RT_:ZBOQ1_X?^?\ !/#_ *&3XK?^&OU/_P"3J/\
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M (-O_P#D^'XJ?]FI^./_ %;OP,K^UROXH_\ @V__ .3X?BI_V:GXX_\ 5N_
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MTMS]2\$K?\1:X O>W^LF V2;OS2Y=VM.:UWNE=I-Z']O]%%%?RT?[#!1110
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MN_\ ;A_Z/*_:L_\ $A_B[_\ -A1_Q"C,/^AM@O\ P17_ ,_7^GH?\3G<,?\
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MPOF")UB\/V_BIF!B>8$JT4D48G6;Y/CG#O$\*YO!*\J=&EB%U:6&Q-&O-_\
M@NG-/R;/VCZ/6:+*?&+@FO*2C3Q6.Q>5S3=E-YMEF.RZC%]W]9Q-"45UG&*=
MUH_[:****_F,_P!< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^4O_@YC\9@R_LC_  \@
MD7*1_%[QGJD)D;=B1O .AZ#((EG"A?W7B-6DGMF8G:MK.@%Y')_*G7[N_P#!
MPW\0T\6?MV:1X/MYB;?X6?!+P/X<N[<H@6/6O$.J>)O'5U.'&97,^C>)O#T;
M*["-!:J8XE9Y9)OPBK^GN",,\+PMD]-JSGAYXE^:Q5>KB8O_ , JQMY6/\BO
MI YI'-_&'CG$PES0P^9T,KC9W499/EV#RJK%=K5\'5<E_.Y7UN%%%%?5'XX%
M%%% !1110!]S_P#!,OPNWB__ (* _LBZ2L'V@VGQQ\%>*/+V2OM7P1J \:-/
MB$JX^S+H!N=Y/E1^5OG#0+(I_P!'FOX)/^"$O@O_ (2S_@I!\*-4> 7%O\/_
M  E\4O&EPCHLD2;O >L^#K.>5'MKA<VVI^+[&>V<O:-#>QVT\=SYL4=O<?WM
MU^"^*E?GSS!4$[JAEE.3\IUL3B&U_P" 0@_F?Z0_0ZP#H>'N?YA*/++'\6XB
ME!V^.C@LJRM1DGU2K8C$0MT<7W"BBBOS$_K<**** "BBB@ HHHH **** "OY
M>_\ @YC_ .1%_9'_ .QL^+__ *9_ %?U"5_+W_P<Q_\ (B_LC_\ 8V?%_P#]
M,_@"OK^ O^2MRC_'B_\ U Q9^(?2/_Y,MQO_ ->,E_\ 6DR8_DCHHHK^F3_)
M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1AJ]!I[6K4I4W?R]X]7(LQ>49WDV;*]\KS7+\Q7+K*^"Q='$JR[_ +K3S/\
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M@!\F&[\1>(O"3R,Q5'DM((\EV0'ZS@?%+"<4Y3-NT:U:IA9:V3>*HU*%-?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>2S\9Z_,@PTTGE^*%\ VDJ1A(S!?RB:8*5M[G]\:_A-_X+S?M%)\:?VX=6\
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M-G^@%_P3%^$C?!+]@C]F#P-/:&RU*7X9:;XWUNWD!^TPZW\3KN]^)&J6UXS
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M>_[2S?+_ *O''0SEXI6RO,,"JOM7A,/K751P]G^[<.>?-_*?_P 0R'_5[?\
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M?_Q#(?\ 5[?_ )K;_P#C\H_XAD/^KV__ #6W_P#'Y7]6%%'_ !$#B[_H;_\
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M0 4444 %%%% !7^=#_P54_Y2'_M9_P#95M0_]-FEU_HO5_G0_P#!53_E(?\
MM9_]E6U#_P!-FEU^H^%7_(YS'_L6/_U*PY_'_P!,K_DA>%O^RLC_ .J?,S\_
M:***_=S_ #G"BBB@ HHHH _H$_X-O_\ D^'XJ?\ 9J?CC_U;OP,K^UROXH_^
M#;__ )/A^*G_ &:GXX_]6[\#*_M<K^=?$K_DJ*W_ &!X/_TVS_43Z*'_ ":+
M!_\ 8^SO_P!/4@HHHKX$_I0**** "BBB@ HHHH **** "BBB@ HHHH *XCXF
M>!M,^)_PW^(/PUUK;_8_Q#\$>*_ VK;D\Q?[,\6Z#?Z!?[HPR%U^RZA+E-R[
MAE=PSD=O150G*G.%2#<9PE&<)+>,HM2BUYII-&5>C2Q-&MAZ\(U*->E4HUJ<
MM8U*56#A4A)=8SA)Q?DV?Y6_B+0=4\*^(-=\+ZY:O9:WX;UC4]!UBRD^_::I
MH][/I^H6K\#Y[>[MYHFX'*'BL>OTD_X*Y?!MO@G_ ,%!_P!HS0X+,VNC>,O%
MD?Q9T!UC,5O=6?Q0L;;QAJC6:8"K;6/BG4O$.C*L8$4<NF2QQ 1(@'YMU_7>
M7XN&/P.#QL+<F+PM#$QMT5:E&IR^3BY<K3U333U1_B/Q+DU;ASB+/<@Q"DJV
M2YOF.5U'+>3P.+K893V2<:BIJ<9)<LHR4H^ZT%%%%=9X@4444 %%%% '[V_\
M&\GQM7X?_MG>(OA/J%V(=(^/'PRUG2K&V:01B?QKX ?_ (330Y6+.$<1>%K;
MQ[;)"$,SSWT!BD14ECF_MSK_ #"/V<OC!J?[/_Q[^#_QKTAI3=_#+XA^%?%\
ML$*JSZAIFDZM;3ZWI#*[(&BUK1OM^DSJ)(F,%[($FA<K*G^G'H>MZ5XET71_
M$>A7T&IZ'K^EZ?K>C:E;%FMM0TK5;2&^TZ^MV958P7=G/#<1%E5C'(I*@Y _
M!O%++GA\WPF8QC:GF&%]G-]\1@VH2;?2]"IAU%/5\DK7L[?Z._0^XH69<$9U
MPO6J<V(X:S?ZSAX.2]W+,[A.O3C"+U:AF.&S*=1K2+Q%-.SDG+4HHHK\P/Z[
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /XO_ /@XR^!1\%_M/_#+
MX[:=:B+2?C=\.FT76)DC4M-XX^%ES;:5>W,\L87:+CP9KW@:SM(YP97.D7K1
M32Q1^3:?SOU_>M_P7,_9\/QO_8+\;>)-,L3=>*O@)K.E?&+2#"B_:&T/25N-
M$\>0/+@LEA;>#M:U7Q)=Q#"RS^&K$MS$A'\%-?TCX?9DLPX;PM.4KULNG/ 5
M+O7DI6GAW;=16'J4Z:>S=.5GHTO\JOI-\*/AGQ6S?%4J7)@>**&'XCPK2]UU
ML4I8?,XN2T=269X;%XF<=)1AB:3DFI*4BBBBOMS^? HHHH **** .O\ A]XY
M\1_##QYX,^)'@^].F^*_ /BK0/&7AN_!E'V37/#6J6NL:7.PAEAE:-+RSA,L
M:31M)'OCWKNR/]-3X!_&/PS^T)\%?A?\;?"#J?#_ ,3?!6A>+;.V\Y)Y=+GU
M2RCDU/0KR6/"'4?#^JB]T/4U7B/4=/NH_P""O\OROZZ_^#<W]JY->\"?$G]C
M_P 4:GG5? EW<_%+X6PW-PI:?PAX@O8;;QUH5C"VSRXM!\5W-CXB2*,S2W4O
MC75YV6**P9F_,_$W)WC,IHYI2C>ME=1^ULM98/$.$*C=M7[*M&E-7TA"5:6B
MO?\ K+Z)7',<BXTQO".-K*& XOPT?J?/*T*>>99"K6PT4Y>[#ZY@IXR@[-2K
M8BG@J24I<B7].M%%%?@9_I,%%%% !1110 4444 %%%% !1110 4444 %%%%
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M7B7&NWNQEEW)'+=7IS?VO7P$U'5RITZK2M&3C^WM%%%?S6?ZO!1110 4444
M%%%% !1110 4444 %?R]_P#!S'_R(O[(_P#V-GQ?_P#3/X K^H2OY>_^#F/_
M )$7]D?_ +&SXO\ _IG\ 5]?P%_R5N4?X\7_ .H&+/Q#Z1__ "9;C?\ Z\9+
M_P"M)DQ_)'1117],G^2P4444 %%%% '6> O^1Z\%_P#8V>'/_3Q9U_J:5_EE
M^ O^1Z\%_P#8V>'/_3Q9U_J:5^,>+7\3(?\ !F7_ *5@3^\_H5_[MXC?]?\
MA7_TWQ"%%%%?CQ_<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %
M#5=+TW7-,U'1=9L+/5='UBPO-+U72]1MH;S3]2TW4+>2TOK"^M+A)(+JSO+6
M:6WN;:9'AG@D>*1&1F!_@5_X*U?\$[=2_8<^-KZWX,L+RY_9W^*M_?ZG\--4
M(FN$\*:ES=ZO\--7NW+L+S0P[7'AVXNI&FUGPR8)?.N]2TO7&M_[^:^??VH_
MV;/AS^UK\$?&OP-^)]BL^@>++!O[/U6*&.75/"?B6T2230/%VA/(5\G5]"OF
M6XB'F)%?6K7>E7OFZ=J%Y!+]5PCQ+5X<S*-63E/ 8EQI8^@KN]._NUZ<=O;4
M&W*/\\'4I7CS\T?QOQK\*<'XI\*U,'3C2H<294JV,X=S":45#$N"]KEV(J;K
M YC&$*59W:H5H8?%J,_J[IU/\R&BO?/VG/V<?B1^R?\ &OQM\#/BGIWV3Q+X
M/U#R[?4;=)?[(\4^'[L&XT'Q;X>N)57[7HFO:>T=W;-Q/9S_ &K2M1BM=6TZ
M_L[?P.OZ:HUJ6(HTL10J1JT:U.%6E5@^:%2G4BI0G%K>,HM-/LS_ "5QV!QF
M68W%Y=F&&K8/'8#$UL)C,)7@Z=;#8G#U)4J]&K!ZQJ4ZD90DGLTPHHHK0Y0H
MHHH *DAFEMY8KBWED@G@D2:&:%VBEAEB8/'+%(A5XY(W571T8,C ,I! -1T4
M FT[IV:U36Z?<_NN_P""-/\ P4@B_;!^$P^$'Q3UJ-_VC/A#HMG#JMS>3*MW
M\3O ]L8M/T[QW &(:YURP<VNE>-T0.QU&;3]>W*FOM;6/[95_E\_ KXV_$/]
MG/XL^"?C/\+-:DT+QMX$UF#5]+N1O>TO8ES#J.B:O;(\8O\ 0]=TZ6YTG6;!
MW5;O3KNXAWQNR2)_HH_L3_M??#S]MKX!^%_C5X">.QN[H?V)X\\'R7276H^
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M_P"318/_ +'V=_\ IZD%%%%? G]*!1110 4444 %%%% !1110 4444 %%%%
M!1110!_)O_P<I_ \V^N_LZ?M(:=:9CU/3/$'P6\67@C=5BN-)N)_&W@.)I%W
M12RWL&J?$+=YGE3)%ID*H;F,L+/^6>O]#C_@KE\ Q^T)^P-\=?#]G9M>>)O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0YU"O"M2IE%%%>"?HP4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5_G0_\%5/^4A_[6?\ V5;4/_39I=?Z+U?YT/\
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M%% !1110 4444 %%%% !7\O?_!S'_P B+^R/_P!C9\7_ /TS^ *_J$K^7O\
MX.8_^1%_9'_[&SXO_P#IG\ 5]?P%_P E;E'^/%_^H&+/Q#Z1_P#R9;C?_KQD
MO_K29,?R1T445_3)_DL%%%% !1110!UG@+_D>O!?_8V>'/\ T\6=?ZFE?Y9?
M@+_D>O!?_8V>'/\ T\6=?ZFE?C'BU_$R'_!F7_I6!/[S^A7_ +MXC?\ 7_A7
M_P!-\0A1117X\?W*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %9VL:/I/B'2-5T#7M-L-:T/7-.OM'UK1]4M(+_3-6TG4[:6RU'3=1L;I
M);:]L+^SGFM;RTN(Y(+BWEDAE1XW93HT4TVFFFTTTTT[--:IIK5-/9DRC&<9
M0G&,X2BXRC)*491DK2C*+NG%IM----.ST/\ /S_X*N_\$\=6_84^.3W'A.SO
M[[]GOXHW.H:S\*==E,]W_P (].DGGZO\,];O9C),=7\+^=&^CW=Y+++X@\,3
M6&H?:KK5K3Q#!IWY5U_IJ?M6_LQ?#?\ :_\ @;XT^!?Q/L]^B^)[03Z/KEO!
M%+K'@SQ98+))X>\9>'Y)2ODZKHEVY8Q"6.#5=,GU'0=1\W2=6U"VG_SH/VE?
MV=_B-^RK\:O'/P,^*6G"R\4^"M4>V6]MUD.D^)-$N0+G0?%?A^XE1&NM#\0Z
M9);ZC8NZ1W-N)9-/U&WL]4LKZRMOZ*X%XJ6>X+ZGC*B_M7 TXJJY/WL7AU:$
M,4KZNHFU#$I7M4<:FBK*,?\ +KZ17@Y+PZS_ /MW(\-)<'<08BI+"1IQ;IY+
MF<U*M6RB;5U##SBIXC*W*S>'C6PMI2P4JM7PJBBBOO3^;@HHHH **** 'QR2
M12)+$[Q2Q.LD<D;,DD<B,&1T=2&1T8!E92&5@"""*_NB_P"",?\ P4BC_:\^
M%(^"_P 5]<2;]H[X0Z);K?7M].OVSXI> +22#3M.\<Q%SYMSX@TAIK'1?'0)
ME>XOY],\2>:3XAN;/3/X6J]5^"/QH^(?[/'Q5\%?&;X5ZY)X?\=> M9@UG1;
MX!Y+6?:KP7VDZM:I)$-0T/6].FNM(UO39)$CU#2[V[M'91+N7YKBGAVAQ'EL
M\-+EIXNCS5<#B)+^%6MK";2;]C624*JL[>[447.G _5_![Q0S#PLXLH9M3]K
MB,DQWL\'Q%ED):8S <[:KT82:A]?R^4I8C!3DX.3=;"RJ0H8JLW_ *A=%?)7
M[$_[7WP\_;:^ ?A?XU> GCL;NZ']B>//!\ETEUJ/@/QY86]M)KGAF_D58VG@
M07-OJ6AZBT,']K^']0TS4C;VLMS-9VWUK7\QXG#5\'B*V%Q-.5'$8>I*E6I3
M5I0J0;4HOH]5HTVI*THMIIO_ %QRK-,OSO+<#G&58JECLMS+"T<9@L70ES4Z
M^'KP4Z<XW2E%M.TX34:E.:E3J1C.,HHHHHK ] **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_.A_X*J?\ *0_]K/\ [*MJ
M'_ILTNO]%ZO\Z'_@JI_RD/\ VL_^RK:A_P"FS2Z_4?"K_D<YC_V+'_ZE8<_C
M_P"F5_R0O"W_ &5D?_5/F9^?M%%%?NY_G.%%%% !1110!_0)_P &W_\ R?#\
M5/\ LU/QQ_ZMWX&5_:Y7\4?_  ;?_P#)\/Q4_P"S4_''_JW?@97]KE?SKXE?
M\E16_P"P/!_^FV?ZB?10_P"318/_ +'V=_\ IZD%%%%? G]*!1110 4444 %
M%%% !1110 4444 %%%% !1110 5\U?MA?L\:-^U9^S1\8?@+K'D1/X^\(7MK
MX>U"X7,>B^--+>+7/!&N28!D,&D>+--T>^O(HFC>ZL8;JS\V-+EV'TK16V'K
MU<+7HXFA-PK8>K3KT9K>%6E-3A)><913^1Q9EE^$S;+\?E6848XC YE@\3@,
M;0G\-;"XRC/#XBE+RJ4JDXOJKW6I_E=>)O#>N^#?$?B#PAXHTN[T/Q-X5UO5
M?#?B+1;^/RK[1]=T._N-,U?2[V(%A'=Z?J%K<6ES&&.R:%UR<9K$K]]?^"_O
M[(<GP9_:8T[]HKPMI8@^'W[1L$UWK36D'EVFC_%OP];6UOXG@G$0,<!\7:4=
M-\6V\TS)/JVM2>,94C*V$LC?@57]7Y-F=+.,KP694;<N*HQG."=_95E[E>B^
MMZ5:,X:[J*>S1_C#QWPEC>!>+L]X5QRFZN48^K1HUIQY?K>!J6KY?C8I)+EQ
MF"J4,19? ZC@[2BTBBBBO3/D@HHHH **** .@\)^*_$7@3Q3X;\;>$-6N] \
M5^$->TGQ/X:URP94O='U[0K^#5-(U.T:1)(Q<6-_:V]S#YD<D9>-1(CH64_Z
M/G[!_P"UKX9_;3_9H\ _&W1'L;;7[RT_X1[XD^'+.4R?\(E\2-$@MD\3:*R/
M^]CM)WGM==T,S9EG\.:SH]S(?,F=5_S8Z_8[_@C)^WK_ ,,??M%1>!_'NM?8
MO@+\=;O2O#/C66^N-NF^"_%B22VW@[XA RL(;&TM+J\?0_%MR'MX#X;U%M7O
MS=2>&-+@3X7CWAUYWE+Q&&I\V89:IUZ"BO?KT&D\1AUUE*48JK2CJW5IJ$;>
MUE?^BOHW>*$> .,XY9FF(]EPSQ5*AE^82J2M1R_,(SE'+,TDY-1ITZ=2K/"8
MVHW"$<)B98BJY?4Z45_>E12*RNJNC!E8!E92&5E89#*1D$$$$$$@@Y%+7\XG
M^IP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(O#7B'2+E[/5-%UO2+N*^TW4K"YC(>&YM+N&*:)AD;DPRLI93_?U_P $N_\
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M44 %%%% !7\O?_!S'_R(O[(__8V?%_\ ],_@"OZA*_E[_P"#F/\ Y$7]D?\
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M_P"1SF/_ &+'_P"I6'/X_P#IE?\ )"\+?]E9'_U3YF?G[1117[N?YSA1110
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M?&C2_P!K+P+I+1?#[X[WYTSX@QVL)%IX>^,=G9RW$E[*5"QP0?$30[*768D
MDDF\1Z%XNOKJ93J5G#7ZOX8Y\L/BJV18F=J6,;Q&"<G91Q4(KVM%7T7MZ45*
M*NE[2CRI.=4_C'Z7'AO+-,HP/B)E>'YL9D4(9;Q!&G&\ZV3UJS>"QLE'63R[
M&5IT:LK2D\-C54G*-'!:?SO4445^XG^>H4444 %%%% !1110!_;-_P $,_\
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M#AO&3YI*>!E->TP%6J[J6,RNI..&KWESU*+PN+E&$<7"*91117U)^/!1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI^./_5N_ RO[7*_BC_X-O_\ D^'XJ?\ 9J?CC_U;OP,K^UROYU\2O^2HK?\
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M )$7]D?_ +&SXO\ _IG\ 5_4)7\O?_!S'_R(O[(__8V?%_\ ],_@"OK^ O\
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MHXS$49RC@<)5C[L\#@ZDI5(N<,5C,11J.A HHHK]%/Y="BBB@ HHHH ****
M"BBO6O@;\#OB=^T=\4/"OP>^$'AB\\5^.?%]^MGIUA;*4M;.V7#W^M:U?%6@
MTC0-&M?,OM8U:[*6MC9Q22NQ;9&\5:E.C3J5JLX4J5*$JE2I.2C"G""<I3G)
MM*,8Q3<FVDDFV=&$PF*Q^*P^"P6'K8O&8NO2PV%PN'ISK5\1B*TXTZ-&C2IJ
M4ZE6K4E&$(03E*322;9VW[*/[+/Q5_;$^-/AGX)_"72C=ZSK,BWNOZ[<QR?V
M%X'\(VUW:6^M^-/$US&,VVC:,MY "B%KS5-1N;#1-*AN]7U.PM)_]#?]D?\
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M#5<'BH0FW%QJT*J33C.,HQJ4W4P]>*C7PU:OAZE*M,HHHKB/>"BBB@ HHHH
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M!Q^"K5,/B\'BJ4Z&(P]>E)QJ4JU*HHSA.+5FI)=UHTPHHHK4Y HHHH ****
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M0M/"X6>L*N9U(2=/'8^G>$(N>#P4W0=?$8THHHK\\/Z="BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OY>_P#@YC_Y$7]D?_L;/B__ .F?
MP!7]0E?R]_\ !S'_ ,B+^R/_ -C9\7__ $S^ *^OX"_Y*W*/\>+_ /4#%GXA
M](__ ),MQO\ ]>,E_P#6DR8_DCHHHK^F3_)8**** "BBB@#K/ 7_ "/7@O\
M[&SPY_Z>+.O]32O\LOP%_P CUX+_ .QL\.?^GBSK_4TK\8\6OXF0_P"#,O\
MTK G]Y_0K_W;Q&_Z_P#"O_IOB$****_'C^Y0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_&'_@L9_P3A@_;
M-^$/_"SOAEHT3_M)_"#1[N;PLEM$B77Q*\&0R3ZCJGPVNY5 >;4XY9;O6/ <
MDYDBM]?FOM%_T.U\57VI67[/45WY9F6*RC'8?,,'/DKX>:E&]^2I%Z5*51)K
MFI58-PG&Z?*VXN,DI+YOB[A7)^-N'LSX9SW#_6,NS.@Z4^7E5;#5HM3P^,PL
MY*2I8K"5HPKT*G+**J04:D9TY3IR_P J2XMY[2>>UNH)K:YMII+>YMKB-X9[
M>>%VCF@GAD59(IHI%:.2.15='5E90P(J*OZ9?^"[G_!-G_A =>U/]MGX*:!L
M\$^+-3B_X7WX;TNVQ#X5\8ZM=K;VOQ)M8(%"0Z%XRO[B"R\4#8GV'QA<6^JM
M)<KXJN5TK^9JOZCR/.<+GN74,PPC]VHN6M2;3GA\1%+VM"I;[4&TXNR4Z<H5
M(KEFC_(#Q!X%SCPZXHS#AC.87JX67M<%C(PE##YGEM64OJF88:]_W=>,91J0
M4I/#XFG7PM23JT)A1117K'Q04444 %%%% 'Z%?\ !-K]O'Q7^P9\?M/\;Q'4
M-8^$_C'[#X;^,O@JUDWG6O"XN6>WU_2;662.U_X2[P?-//JGA^>1H&NH9=5\
M/27EG8>(+ZX3_0N\$^-?"GQ(\(>&?'_@77M/\4>#?&.B:=XC\,^(=*F\_3]8
MT75K:.\L+ZV<JCA)H)49HIHXKB"3?!<113QR1K_ECU_1U_P0M_X*3?\ "G_%
MUA^QS\:=?\GX5_$#6Y#\'_$>JW.+7X?_ !"UF?=)X2N+B=\6GA3Q]J#C[ J,
M+71_&UR)V@2W\4ZSJ-C^8>(7"G]HX>6=8"E?'X2G_M=*"][%X6FOC26LJ^&B
MKK[52BG"\I4Z4'_77T8O&7_5;,Z? /$>+Y>'<ZQ2_L7%UY_N\ESC$32^KRG)
MVI9=FM224[OV6&Q[AB&J=/%8VLO[)J***_!C_1X**** "BBB@ HHHH ****
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M_P#DRW&__7C)?_6DR8_DCHHHK^F3_)8**** "BBB@#K/ 7_(]>"_^QL\.?\
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M.$O.*K17GT_">)_ID</895*/"/"V9YK65XPQF=5Z&5812Z5(8;"RQ^*Q%/\
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M*ME7#]1)2B\,IJV-S*E+5X^I%4L/42^HTXSIK&5BBBBOSD_J8**** "BBB@
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M\_H5_P"[>(W_ %_X5_\ 3?$(4445^/']RA1110 4444 %%%% !1110 4444
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M",XO_MV2:_ Z,-B\7@JJKX/%8C"5EM6PU:I0JK6^E2E*$UJD]'NKGZ$>%_\
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MK8K$5\36E\57$5:E:I+UG4E*3^;"BBBK, HHHH **** "BBB@ HHHH ****
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M(>*DE%_Y75%?VC_MB?\ !OK\!?BQ_:GC#]EK7_\ A0'CFX\ZZ_X0K5!J&O\
MP?UB\?+^5!!NNO$_@/[1,[/+/HTOB#0[*%([73/!MK&-R_R\?M0?L&?M5?L?
M:E);_''X3ZYHF@-/Y.G_ ! T55\2_#K5M\JPVYM/&&C_ &C3+.YNF>,PZ/K;
MZ3KRK)'Y^E0EP#^SY)Q;DF>J,<)BHTL5)*^"Q7+1Q2=KM0BY.%=+O0G427Q<
MKT/X,X_\%/$#PZG5JYUD\\7E%-ODS_*%4QV4RA>RE7JQIPKY>V]%#,:&%<Y7
M5+VD4I/X_HHHKZ4_)PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK[#_9>_8)_:K_ &PM1BA^
M"'PHUS6?#HGD@O\ XAZXA\-?#?2FA<QW*7/C'5E@TR\O+9@1+H^B-JVNXR8]
M+D 8C^H3]CO_ (-]?@+\)_[+\8?M2Z__ ,+_ /'-OY-U_P (5I8U#0/@_H]X
MF'\J>#=:^)_'GV>9%>*?69?#^AWL+R6NI^#;J,[F^:SOBW),B4HXO%1JXJ*=
ML%A>6MBF[72G%24*"?>O.FFOAYGH?K' /@IX@^(LZ57)LGJ8/**C7-G^;JI@
M,IC!M)SH59TY5\P:O9PRZABG%V]I[.-Y+^7_ /91_8(_:A_;.UV'3?@E\.-0
MO?#J79M-8^)?B1;GP_\ #+PZR<S#5/%DUI/#=7< PTFB^'[;6_$3(PDAT>6,
M,R_UQ?L/_P#!#O\ 9K_9@DTCQU\7!:_M%?&.QDM[ZUU'Q1I,<'PV\):A%F2)
M_"_@2YEO;?5+^SF8-#X@\7SZO.MS:66JZ)I/A>^C8']G/#?AKPYX.T+2_"_A
M#P_HGA7PSH=I'8:+X=\-Z58:'H6D6,1)BLM+TC3(+73]/M(RS&.WM+>&%"3M
M09-;=?C'$''^<9RJF'PTGEF E>+HX>;>(K0[5\4E&=FM)4Z*I4W%N-155J?W
MGX:?1IX'X%>'S+-H1XNXBI<E2.-S/#P668*M&TN;+LIDZM%3IS2E3Q6-GB\1
M"<(U<.\+)N*155%5$4*J@*JJ JJJC 50,        # I:**^#/Z-"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K^7O\ X.8_^1%_9'_[&SXO_P#IG\ 5_4)7\O?_  <Q_P#(B_LC_P#8V?%_
M_P!,_@"OK^ O^2MRC_'B_P#U Q9^(?2/_P"3+<;_ /7C)?\ UI,F/Y(Z***_
MID_R6"BBB@ HHHH ZSP%_P CUX+_ .QL\.?^GBSK_4TK_++\!?\ (]>"_P#L
M;/#G_IXLZ_U-*_&/%K^)D/\ @S+_ -*P)_>?T*_]V\1O^O\ PK_Z;XA"BBBO
MQX_N4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *YSQAX0\,>/_"GB/P-XTT33_$OA'Q?HFI^&
M_$WA_58!<Z;K.AZS9RV&IZ;>P-CS+>[M)Y89 I5U#[HW1U5AT=%.,I1E&49.
M,HM2C*+:E&2=U*+5FFFDTT[IZHBI3IUJ=2E5IPJTJL)4ZM*I&,Z=2G.+C.G4
MA).,X3BW&49)QE%M---H_P [G_@IE^P1XG_8-^/M]X5ACU#5O@WXY>_\1?!C
MQC=J9&O] 2:/[=X5UBZ1! ?%?@N>Z@TW5@I1M2T^;1_$:VUG%K:6-I^<M?Z5
M?[;'[(/P\_;:^ ?BCX*^/4CL;NZ']M^ _&"6J76H^ _'EA;W,>A^)K"-FC:>
M!!<W&FZYIRS0?VOX?U#4]-%Q:RW,-Y;?YTOQJ^#?Q!_9]^*?C;X-?%/0Y?#O
MCOP!K<^B:[ISEG@=T2.XLM3TRY9(UU#1-;TV>SUC0]3B00:GI%]97\'[JX2O
MZ/X'XICQ!@/J^*FO[5P,(QQ"=D\31TC#&175R=H8A1TA6:E:,:U.)_E?](/P
M?J>&O$?]I910F^#N(*]6KE<DI2CE6-=ZN(R2M/6T:<>:MELJCYJV"4J?-6K8
M+$U'Y=1117W!_/04444 %%%% "JS(RNC%64AE925964Y#*1@@@@$$$$$9%?W
M"_\ !%3_ (*2+^U1\,H_V?OB[KJS?M!?";0XA8:IJ-P#>_%/X>6!AL[/Q#YL
MK>9>^*O#2R6FE>+ 2]SJ$#:=XD9[F>]UDV/\/->D_!_XM^/O@1\3/!GQ=^&&
MO7'AOQUX#UNUUW0-5@RRK<0%DGLKZWW+'?:3JEG)<:9K&FSYMM2TR[N[&Y5H
M+AU/SG%'#U#B/+)X2?+3Q5*]7 XAK6C72^&36OL:R2IUHJ^G+447.G"WZIX0
M^)V8^%O%F'SBA[7$9/C/9X/B'+(2]W'9<YW=2E&34%CL#)RQ&!JMQ:G[3#RG
M'#XJNI?ZB]%?&W["G[9?@']N+X ^'/C!X0:WTS7X]F@_$KP4+D3WO@?QU9VT
M,FJ:3)N/G3:3>++'JGAS4G51J6BW=L\HAOX;^SM?LFOYBQ6%KX+$UL)BJ4J.
M(P]25*M2G\4)Q=FM+II[QE%N,HM2BW%IO_7/*,WR[/LKP&<Y1BJ6.RS,\+1Q
MF"Q5%WA6H5X*<)6:4H25^6I3FHU*52,Z=2,:D)111117.>B%%%% !1110 44
M44 %%%% !1110 5_G0_\%5/^4A_[6?\ V5;4/_39I=?Z+U?YT/\ P54_Y2'_
M +6?_95M0_\ 39I=?J/A5_R.<Q_[%C_]2L.?Q_\ 3*_Y(7A;_LK(_P#JGS,_
M/VBBBOW<_P YPHHHH **** /Z!/^#;__ )/A^*G_ &:GXX_]6[\#*_M<K^*/
M_@V__P"3X?BI_P!FI^./_5N_ RO[7*_G7Q*_Y*BM_P!@>#_]-L_U$^BA_P F
MBP?_ &/L[_\ 3U(****^!/Z4"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YOQ?X-\)?$'PUK'@WQWX
M8T#QEX2\06<NGZYX9\4:18:[H.KV,PQ):ZCI6IP7-C>0-P?+G@=0P5P R@CI
M**<92C*,HR<91:E&46U*,D[J46K---)IIW3U1%2G3K4ZE&M3A5I582IU:52$
M9TZE.<7&<*D))QG"<6XRC).,HMIIIG\QO[;/_!O1X0\4OJWCW]BOQ';^!-;D
M^T7UQ\&/'6I7UWX,OI</*UOX+\7RI?ZSX:EF(V6VD^)/[;TA[F9476_#FF1+
M'%_+C\;/@!\:/V<?&5QX ^./PV\5?#3Q7 ))(M/\2:<T%OJEK%(86U'P_K%N
MUQHGB72#,&A36/#VHZGI4LJ/'%>.Z.J_Z@%>4_&+X&_!_P#:"\'W7@+XU?#G
MPI\2O"=WO;^R?%.E07_V*X=#']OT>^PFI:#JL:$B#5]$O-/U2VZV]W$>:_1\
M@\2,SRY0P^:QEFF$C:*JRDHXZE%::5I>[B++7EK_ +R3_P"8B*T/Y7\2/HJ\
M(\4/$9GP?5AP?G-3FJ/"4Z3J<.XNH];2P5.U7+')V7M,O;PU-7:RZI-\Q_EZ
MT5_5_P#M<_\ !N?87"ZIXN_8R^(IT^X,DUVGP?\ BQ>2SZ>8R!(;+PK\1K6V
MFOK9HMK0Z?IWB[2]0^T-+&=1\96BPO-+_-K\=_V9?C[^S)XF/A+X\?"KQ?\
M#;5I))TL)=>TUO[$UQ;=VCEN?#?B:R:[\.>);-'1@;S0=5U"V!!!E# @?L63
M\2Y-GD4\!C:<JS5Y82JU1Q<+*[O0F^::C]JI2=2E_?9_#'''A/QYX>5IQXDR
M+$TL$I\M+.<&GCLFKW?+!QQ]"+IT)U'\&'QD<+BFM7ATFCPJBBBO>/SD****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M -C9X<_]/%G7^II7^67X"_Y'KP7_ -C9X<_]/%G7^II7XQXM?Q,A_P &9?\
MI6!/[S^A7_NWB-_U_P"%?_3?$(4445^/']RA1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5^'7_!:#_@FVO[6_P +/^%W?"30EF_:,^$>C7#1:?I]N&O?BK\/;,W%_?\
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MA3ITXQA3ITXJ$(0@E&,(0BE&,8Q248Q22222204444BPHHHH **** "BBB@
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MM_X27A#_ ..UU+Q&X5:N\;7CY/!8JZ];4VON;/)G]%OQDC)I9#EU1:>]#/\
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M=TC_ .0ZZNBCVE3_ )^3_P# I?YA]5PO_0-A_P#P33_^1\E]QRG_  @?@?\
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M[/\ _P"&:^'7_P SE'_#)O[+'_1M'[/_ /X9KX=?_,Y7T!16GUW&?]!>*_\
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MT?\ "!^!_P#H3/"G_A.Z1_\ (==711[2I_S\G_X%+_,/JN%_Z!L/_P"":?\
M\CY+[CE/^$#\#_\ 0F>%/_"=TC_Y#H_X0/P/_P!"9X4_\)W2/_D.NKHH]I4_
MY^3_ / I?YA]5PO_ $#8?_P33_\ D?)?<8FF^&O#FC3O=:/X?T32KF2)K=[C
M3=*L+&=X&>.1H7FM8(I&B:2*)VC+%"\<;%2R*1MT45+;D[MMONVV_O9M"$*<
M>6G",([\L(J,;][1204444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *X_QM\// 'Q+T=_#WQ&\#>#_'^@2[_,T/QMX9T7Q5H\GF+LDWZ9KME?
MV3[T 5]T!W*-K9'%=A151E*$E.$I0G%WC*+<91?=2333\TS.M1I8BE.C7I4Z
MU&K%PJ4JT(U*52#WC.G-2A.+ZQDFGU1^5WQ8_P""+G_!.OXKFYN9/@3!\.M8
MN P&K_"?Q)X@\$BV#*P_T;PU;7UWX&0JS!U9_"LC!D523$7C;\V_B9_P;3?#
M*_:XG^#O[3OCGPJH>22VTSXD^!]!\=B1"'\NUDUGPSJ?P\:UPQ3=>#1+X[$9
M?L;,X=/Z=:*^AP?%W$N!LL/G&,<8[0Q$UBX)+[*CBXUE&/E%*W2S/S#//!+P
MHXB<Y9EP-D<:M2[G7RRA4R2O*3U]I.KDU7 3J3OJY5'-RVES)M/^([XA?\&[
M/[;WA?[1<>"?%?P.^)UFOV@VMMIGBW7O"^OS+%S$L]CXK\+:;H=M+=*0L2Q^
M*+J*.42+/-%&L<TOQ+XY_P""2W_!1?X>O*NM_LJ_$/5%CW$2^!IO#7Q)25%
M8/$OP^U[Q+,=ZL"L31)."3&\*2I)&O\ HET5]+AO%#B&C95Z.78M=7.A5I5'
MZ2HUX4UY_NGY6/RC-?HA>&>-<IY=C^*,FF_@IT<PP>-PL?6GCLOK8F5NG^V1
MZWOI;_+\\8?L_?'GX>M*GC_X)?%WP.\!99E\8?#;QEX9:%D,H<2KK6BV1C*&
M"<,' *F&4''EOCR*O]6"N(\3?#+X;^-3*WC+X?>"/%K3@K,WB;PIH.O&96MU
MM&64ZK879D#6J);$/D&W583^[4*/;H^+,M%B,C3?65''N/W4YX27_IP^ Q_T
M+:;<I99X@SBOLT<?PY&H[?WL3A\YI[:+3"Z[Z6L_\M:BO]+?7OV%_P!BKQ.)
MO[=_9(_9KOYITACDO7^"/PWAU/RX)%DB2/5;;PY#J4**4"E8;J-7B+PN&ADD
M1O,-0_X);?\ !/74KB:ZN/V2O@_'+.%5UT_0I])MU"1+"/)L]+O;.TMB40%F
MMX(F>4M.Y:9WD;T(>*^5M?O,KQ\'VA4P]1=.LITO/IT7=V^8Q'T,^+XO_9>+
M^&ZROOB,/FF&=M=;4\/BU?X=.;J]=%S?YR]%?Z&G_#GK_@FS_P!&L>$__"J^
M)7_S:T?\.>O^";/_ $:QX3_\*KXE?_-K6_\ Q%7(O^@#-O\ P5@__FT\_P#X
MDW\1/^BBX+_\*\\_^<)_GET5_H:?\.>O^";/_1K'A/\ \*KXE?\ S:UM:;_P
M29_X)SZ5 ]O:_LH_#F6-Y6F+:E-XHUB<.R1H52ZU?Q#?7,<06-2L"2K KF21
M8Q)+*SI^*N26]W 9JWV<,)%6ZZK%R^ZWS14/H;^(+E^\XDX-C'O#$9W.5_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>oric-20250505.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-02T18:15:30.1985+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.oricpharma.com/20250505" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:oric="http://www.oricpharma.com/20250505" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="oric-20250505.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOrganizationsAbstract" xlink:label="us-gaap_HealthCareOrganizationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCareOrganizationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Organizations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationsAbstract" xlink:to="us-gaap_HealthCareOrganizationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001796280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ORIC Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-1787157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">240 E. Grand Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">388-5600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ORIC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $.!I5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( $.!I5K!E!2Q[0   "L"   1
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " !#@:5:1L=-2)4   #-    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $.!I5K!E!2Q
M[0   "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( $.!I5J97)PC$ 8  )PG   3              "  =\!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 0X&E6O&;:/F)!   U!$
M !@              ("!( @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( $.!I5J?H!OPL0(  .(,   -              "  =\,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ 0X&E6I>*NQS     $P(   L
M         ( !NP\  %]R96QS+RYR96QS4$L! A0#%     @ 0X&E6APX9>H_
M 0  / (   \              ( !I!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( $.!I5HD'INBK0   /@!   :              "  1 2  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $.!I5IED'F2&0$
M ,\#   3              "  ?42  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  #\4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="oric-20250505.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="oric-20250505.htm">oric-20250505.htm</File>
    <File>oric-20250505.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "oric-20250505.htm": {
   "nsprefix": "oric",
   "nsuri": "http://www.oricpharma.com/20250505",
   "dts": {
    "inline": {
     "local": [
      "oric-20250505.htm"
     ]
    },
    "schema": {
     "local": [
      "oric-20250505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_986a34b5-c1d7-4941-b34d-26248f38897b",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "oric-20250505.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_986a34b5-c1d7-4941-b34d-26248f38897b",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "oric-20250505.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation State Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security 12b Title",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.oricpharma.com/20250505/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-063540-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-063540-xbrl.zip
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M9W[Y.;VQ\?O0R9WDUZK/_@]02P,$%     @ 0X&E6G>:M'$%(@  @6L"  \
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MS,N]32#O2B]BH+23Z([?0;L'UY]N#\G]@&6\ T\KQ@D\>(DA.[ALA*H+>&<
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MX-.<0_-O)":P[CZ-,"<A+6TOI/A17::!,+R+#%3"4IGT;;!,9F4R&QH$"F?
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ME\&:OI+'ULQQ->W82Q_<2Z@K3JSZD?XW*QB"-UI:3U2-^-X=W$LIOD^/3O2
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MP5-<Q)%,_#8\56I]6D)=<&)5CU]89L*0[8Z1K<'68+N+V)90W!Y;U;JQO'?
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M8RTR,#(U,#4P-2YH=&U02P$"% ,4    " !#@:5:S28DU?0)  #R?P  $0
M            @ 'L%0  ;W)I8RTR,#(U,#4P-2YX<V102P$"% ,4    " !#
M@:5:=YJT<04B  "!:P( #P              @ $/(   ;W)I8RUE>#DY7S$N
9:'1M4$L%!@     #  , NP   $%"      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>oric-20250505_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="oric-20250505.xsd" xlink:type="simple"/>
    <context id="C_986a34b5-c1d7-4941-b34d-26248f38897b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001796280</identifier>
        </entity>
        <period>
            <startDate>2025-05-05</startDate>
            <endDate>2025-05-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_80246073-f633-491c-865c-0e4a74405a2a">0001796280</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_3745995c-b7e8-4bb7-918e-09803bc39944">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_1efe76a2-53eb-4e33-9d0a-76166f413991">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_028b7034-0608-449f-a8b4-781eced48a3d">2025-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_09118753-2756-45b9-88c0-67b4f51ea74c">ORIC Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_28ebae7a-d0b8-4582-b87d-e37402dac0f0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_b22e17ff-bcb2-420b-8dc4-8c60c42a1bf7">001-39269</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_07f4a8ab-c5d4-44d5-b462-3d620683fdeb">47-1787157</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_2dfec7d9-80ba-4250-9bad-74d2c1a0b565">240 E. Grand Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_ab89bef8-d577-42a8-ba2a-4e4c566179b8">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_41f668cd-955f-4357-9b59-9ac6ee45a513">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_f428cd28-5b90-419e-a446-780904cc4004">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_7d7f82e1-059e-48f6-8fa5-7e20b4ad988a">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_6d57ea8d-f287-44b7-8167-ef79e484e22b">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_53dae7c1-8ca8-41d0-af54-cc9fe80996a2">388-5600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_67938873-6375-4a4d-8a08-0bb59e043d27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_b588ddd5-39f7-4746-a261-7cae5315d985">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_dbdba790-45cf-4078-a875-62ca37e41aab">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_9f9f193c-3b7f-48c1-9a42-8521773eaec9">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_f793a11e-233a-455c-b520-ba8f70043cab">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_7dabb238-628a-4b1a-b113-0a12c7b99e63">ORIC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_6d1b598c-820e-4ae7-b745-e10f1049f6f2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_b80923f3-ed6d-4760-992c-8f0e8b43215c">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_986a34b5-c1d7-4941-b34d-26248f38897b"
      id="F_be45a929-e29e-4b3d-8937-0f507b4c20e4">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
